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ABSTRACT 
 
Embryo implantation is a complicated process involving mother and 
conceptus cells differentiation, proliferation and invasion that are 
essential for successful pregnancy. Almost every cell in the human body 
is affected by IGF-1 that is one of the most potent natural activators of 
cell growth and multiplication, and also a potent inhibitor of the 
programmed cell death. bFGF, acting via its receptor FGFR1, is one of 
the factors involved in mediating the angiogenesis, proteolysis and 
apoptosis during the implantation. OBJECTIVE: To establish pregnancy 
inducted difference of appearance of bFGF, IGF-1 and their receptors in 
the embryonic, decidual and tubal tissue. STUDY DESIGN: In this 
study 14 tubal pregnancy and 10 decidual tissue samples were evaluated 
immunohistochemically in order to define the distribution of bFGF, 
FGFR1, IGF-1, IGF-1R. RESULTS: The Mann-Whitney U test was 
used as appropriate for the evaluation of significant differences. FGFR1 
appearance dominated on bFGF in the decidual (z=2.539, p=0.01), tubal 
(z=2.539, p=0.01) and embryonic (z=2.539, p=0.01) tissue. IGF-1 and 
IGF-1R appearance in the decidual, tubal and embryonic tissue was not 
statistically different. It was the same as IGF-1 and IGF-1R expression 
in gravid endometrium, but in the ectopic implantation site IGF-1R was 
particularly absent (z=1.935, p=0.05), only mesothelium and some 
epithelial cells stained. CONCLUSION: IGF-1, IGF-1R, bFGF and 
FGFR1 are widely appearing growth factors in actively developing and   IGF-1 and bFGF in human implantation 273 
 
differentiating of the human embryonic tissue during the first trimester. 
Both endometrial and fallopian tube tissues express more FGFR1 than 
bFGF that testify the stimulation of compensatory adaptation of the 
organ during pregnancy. IGF-1 and IGF-1R richly appear in gravid 
endometrium. IGF-1 is widely distributed in both the mother and the 
embryo tissues but only some of them are IGF-1R marked in a case of 
ectopic pregnancy. The deficit of IGF-1R in the fallopian tube might be 
a result of cell growth restriction and the impaired process of trophoblast 
invasion. 
 
Key words: growth factors, implantation, tubal pregnancy, immuno-
histochemistry. 
 
INTRODUCTION 
Embryo implantation is a complicated process involving mother and 
conceptus cells differentiation, proliferation and invasion that are 
essential for successful pregnancy. Only 25 to 30% of conceptions result 
in a live birth [22]. A significant proportion of pregnancy loss is caused 
by embryo chromosomal disorders, so more than 50% of the first 
trimester spontaneous aborts are aneuploid [6, 13, 18]. Embryo 
implantation failure due to impaired uterine receptivity took place in up 
to 30% of early pregnancy loss [7]. However, 1–2% of embryo 
implantations in the world are ectopic [9, 27]. The research of the 
abnormally implanted embryo had shown no karyotype changes [8, 10], 
so molecular signalling at the time of blastocyst nidation could probably 
be the key to the explanation of normal and abnormal implantation [1]. 
The insulin like growth factor (IGF-1) and the basic fibroblast 
growth factor (bFGF) are found during pre-implantation and 
implantation in uterus [3] in addition, these factors and their receptors 
regulate cellular events of the early embryonic period. As growth factors 
orchestrate cell growth, differentiation and proliferation during 
embryogenesis, the aim of our study was to define the appearance of 
IGF-1, bFGF and their receptors in uterine pregnancy, tubal pregnancy 
and embryonic tissues.  
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MATERIAL AND METHODS 
The study was performed with the permission of the Ethics Committee 
of Riga Stradins University (18.12.2007). Human oviduct parts were 
obtained from 14 patients of Riga 1
st Hospital, who had undergone 
salpingoectomy for tubal pregnancy with informed consent. The human 
embryo and the gravid endometrium tissue were obtained from 10 
patients who had unplanned pregnancy termination in the Riga Medical 
Centre “Elite” with informed consent. Tissue samples were taken from 
January 2007 to January 2008. Age, parity, the contraception method, 
pelvic inflammatory and sexually transmitted diseases episodes, the 
partner count had been carried out for all the patients. 
The tissue samples were fixed in 2% formaldehyde and 0.2% picric 
acid mixture with 0.1 M phosphate buffer (ph 7.2). Then the samples 
were rinsed in the thyroid buffer containing 10% sucrose and embedded 
in paraffin. The tissues were cut into 6-μm-thick sections and were 
dewaxed with toluene and rehydrated through a graded ethanol series. 
The sections were stained with haematoxylin and eosin (H&E) using 
standard procedures to obtain a review picture of the slide.  
We used the biotin–streptavidin method for the determination of the 
basic fibroblast growth factor (FGF basic rabbit polyclonal to bFGF 
(ab16828), dilution 1:200, Abcam, UK); the fibroblast growth factor 
receptor 1 (FGFR1 rabbit polyclonal to FGFR1 (ab10646), dilution 
1:100, Abcam UK); insulin-like growth factor 1 (IGF-I goat polyclonal 
to IGF-1 (MAB291), dilution 1:100, R&D systems, Germany); the 
insulin-like growth factor 1 receptor (IGF-IR mouse monoclonal to IGF-
1R (AF-305-NA), dilution 1:100, RnD Systems, Germany.  
At least five microscopic fields (X200) were analyzed using the 
microscope Leica DM RB (Leica Microsystems, Germany).  
The distribution of these factors was detected semi-quantitatively   
(0/– occasional positive structure in the visual field, + few positive 
structure in the visual field, ++ moderate number of positive structure in 
the visual field, +++ numerous positive structure in the visual field. The 
data were analyzed by the nonparametric rank analysis with SPSS 
Statistic 17 software. A Mann-Whitney U test was used as appropriate 
for the evaluation of significant differences. A p-value <0.05 was 
considered as statistically significant.  
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RESULTS 
The average patient’s age in the tubal pregnancy group was 29.6 years 
(23–43). This pregnancy was the first for 3 of them (25%). n=6 patients 
(50%) had a previously documented pelvic inflammatory disease (PID) 
episode and n=1 had undergone right sided salpingectomy due to the 
previous ectopic pregnancy. Only one of them used the intrauterine 
device (IUD) for contraception. The number of partners and the legal 
abortion count were not significantly different. The average patient’s 
age in the uterine pregnancy termination group was 30.9 years (23–43). 
This pregnancy was current for all the patients. None of the patients had 
any documented PID episode or tubal surgery. None of the patients used 
contraception.  
Routine haematoxylin and eosin slides showed tubal mucosal edema. 
It was typical to see the proliferation of epitheliocytes, the infiltration of 
lymphocytes and leukocytes as well as capillary stasis. Only the 
embryonic structure found in any case of tubal pregnancy were 
chorionic villi binding to the fallopian tube structures or to germ 
membranes (yolk sac as well). No specific finding, despite decidual 
endometrium and trophoblast tissue, was seen in the routine uterine 
pregnancy slides.  
The immunohistochemical analysis of tubal and pregnant 
endometrium tissues resulted in the different appearance of the recurred 
growth factors (Figure 1). 
IGF-1 was widely distributed in the fallopian tube epithelium (Figure 
2) but IGF-1R focally stained the apical surfaces of tubal epitheliocytes 
(Figure3). Despite, epithelium IGR-1R stained only mesothelium and 
was absent in chorionic structures. Cytotrophoblast, sincytiotrophoblast 
and extraembryonic mesenchymal cells contained IGF-1 (Figure 4). 
Peripheral trophoblast focally contained IGF-1 positive cells. IGF-1 as 
well stained macrophages and neutrophils. Endometrium showed 
numerous IGF-1R cells, but IGF appeared in epithelium moderately. 
Trophoblasts contained moderate numbers of IGF-1 cells in a case of 
uterine pregnancy (Figure 5). Peripheral trophoblast widely expressed 
both IGF-1 and IGF-1R. Separate connective tissue cells in endo-
metrium demonstrated IGF-1 and IGF-1R immunoreactivity. IGF-1 was 
widely distributed in both mother and embryo tissues but IGF-1R only 
in some of them. IGF-1 and IGF-1R appeared in embryonic respiratory, 
duodenal and mesonephric epithelia (Figure 6, 7). Embryonic hepar 276  A. Miskova, M. Pilmane, D. Rezeberga 
contained focally a moderate number of IGF-1 and IGF-1R positive 
cells. Mesenchymal cells around the future skeleton and perichondrium 
moderatly demonstrated IGF-1 (Figure 8) and IGF-1R positive cells. 
FGFR1 appeared both in tubal and decidual tissue. Numerous 
positive structures were seen in tubal and endometrial epithelia (Figure 
9).  Citolemmae of muscle cells, endotheliocytes, nerve fibers and 
peripheral trophoblast cells demonstrated immunoreactivity for FGFR1 
in both implantation sites. A moderate number of FGFR1 positive 
structures in extraembrional mesenchyma, citotrophoblast and syncitio-
trophoblast appeared (Figure 10). Tubal and endometrial epithelium 
contained moderately bFGF (Figure 11). A few bFGF positive cells 
were seen in tubal and endometrial stroma (Figure 12) 
The numerous distribution of FGFR1 had been established in 
sklerogenic mesenchyma, perichondrium, in the proliferating cartilage 
area and in degenerating chorda dorsalis of human embryo. The largest 
part of the muscle, nerve fibers’s plasmolemmae and endotheliocytes 
contained FGFR1. FGFR1 immunoreactivity concentrated in the spinal 
ganglions. The epitheliums of skin and its appendages tongue and 
salivary glands have been positive for FGFR1. The mesothelium of 
pleura and pericardium has contained FGFR1. Myocardium has been 
weakly positive FGFR1. bFGF have been shown the same distribution 
in embryonic tissues as FGFR1 but moderately. 
The Mann-Whitney U test was used as appropriate for the evaluation 
of significant differences. FGFR1 appearance dominated on bFGF in the 
decidual (z=2.539, p=0.01), the tubal (z=2.539, p=0.01) and the 
embryonic (z=2.539, p=0.01 tissue. IGF-1 and IGF-1R appearance in 
the decidual, the tubal and the embryonic tissue was not statistically 
different. It was the same as IGF-1 and IGF-1R expression in gravid 
endometrium, but in the ectopic implantation site IGF-1R was 
particularly absent (z=1.935, p=0.05), stained only mesothelium and 
some epithelial cells.   IGF-1 and bFGF in human implantation 277 
 
Table 1. The distribution of bFGF, FGFR1, IGF-1 and IGF-1R in tissue 
Structure/ 
Factor  FGFR bFGF IGF1R IGF-1 FGFR bFGF IGF1R IGF-1 
  Tubal pregnancy tissue  Uterine pregnancy tissue 
Epithelium +++  +  +  +++ +++  ++  +++  +++ 
Myocytes +++  +  0/–  0/–  +++  +  0/–  0/– 
Endo-
theliocytes 
++ + 0/–  0/–  ++ +  0/ 0/– 
Nerve fibers  ++  +  0/–  0/–  ++  +  0/  0/– 
Mesothelium ++ + ++  ++  none  none none  none 
Extra-
embryonic 
mesenchyma 
+++ 0/– 0/– 0/– +++ 0/–  0/  0/– 
Cytotro-
phoblast 
++ 0/– 0/–  +++ ++ 0/–  0/  + 
Sincytiotro-
phoblasts 
+++ 0/– 0/– +++ ++ 0/–  0/  ++ 
Peripheral 
trophoblast 
+ +  0/–  ++  + +  +++  ++ 
Macrophages 0/– + 0/– +  +  +  ++  + 
Neutrophils 0/–  +  0/–  +  +  +  ++ + 
 
 
Figure 1. Immunohistochemical distribution of bFGF, FGFR1, IGF-1, IGF-
1R in tubal and pregnant endometrium tissues. 278  A. Miskova, M. Pilmane, D. Rezeberga 
 
 
Figure 2. IGF-1 was widely distributed in fallopian tube epithelium. IMH 
IGF-1 250X. 
 
 
Figure 3. IGF-1R focally stained the apical surfaces of tubal epitheliocytes. 
IMH IGF-1R 250X.   IGF-1 and bFGF in human implantation 279 
 
 
Figure 4. Cytotrophoblast, sincytiotrophoblast and extraembryonic mesen-
chymal cells moderately contained IGF-1. IMH IGF-1 400X. 
 
 
Figure 5. Trophoblasts contained moderate numbers of IGF-1 cells in a 
case of uterine pregnancy. IMH IGF-1 400X. 280  A. Miskova, M. Pilmane, D. Rezeberga 
 
Figure 6. IGF-1 in embryonic kidney. IMH IGF-1 400X.  
 
 
Figure 7. IGF-1 in embryonic lungs. IMH IGF-1 400X.   IGF-1 and bFGF in human implantation 281 
 
 
Figure 8. Mesenchymal cells around the future skeleton and perichondrium 
moderatly demonstrated IGF-1. IMH IGF-1 400X.  
  
 
Figure 9. Numerous FGFR-1 positive structures were seen in tubal 
epithelium. FGFR1 IMH 400X. 282  A. Miskova, M. Pilmane, D. Rezeberga 
 
Figure 10. FGFR1 in extraembrional mesenchyma, citotrophoblast and 
syncitiotrophoblast. FGFR1 IMH 400X. 
 
 
Figure 11. Tubal epithelium moderately contained bFGF. bFGF IMH 250X.   IGF-1 and bFGF in human implantation 283 
 
 
 
Figure 12. A few bFGF positive cells were seen in tubal stroma. bFGF 
IMH 400X.  
 
DISCUSSION 
bFGF is able to accumulate in the nucleolus where it stimulates 
ribosomal protein transcription [4]. bFGF is the first factor inducting 
mesodermal differentiation in vivo un in vitro and is abundant in the 
cells of mesenchimal and neuroectodermal origin [31]. The embryonic 
digestive tract, lungs, kidney, salivary and sebaceous glands, striated 
and smooth muscles express bFGF [11]. bFGF is one of the factors 
involved in mediating the angiogenesis, proteolysis and apoptosis during 
the implantation [21, 33]. bFGF appears in the maternal circulation 
during pregnancy, with peak values late in the 2
nd trimester. The levels 
of bFGF in the maternal serum correlate positively with the fetal size 
both in the 2
nd trimester and at term [14].  284  A. Miskova, M. Pilmane, D. Rezeberga 
The fibroblast growth factor receptor 1 (FGFR1) is the most sensitive 
bFGF receptor [26]. The widespread distribution of FGFR1 in multiple 
mature organ systems suggests an important functional role in the 
normal human adult tissue [16]. It could be found in the membranes of 
the most anchorage dependent cells also around and in their nuclei [12, 
28]. FGFR1 is a widely expressed membrane receptor of developing of 
human tissues, including neurons, vascular basement membranes, skin, 
and bone growth plates. Our previous data showed FGFR1 participation 
in the regulation of the human embryonic tissue formation [20]. Our 
findings demonstrated that the tubal, decidual and conceptus tissue 
contained more FGFR1 than bFGF. We speculate that the excess of the 
receptor is due to the compensatory adaptation of the organ to the 
gestation process.  
Almost every cell in the human body is affected by IGF-1 which is 
one of the most potent natural activators of cell growth and the 
multiplication and a potent inhibitor of the programmed cell death [32, 
5]. In addition to the insulin-like effects, IGF-1 can also regulate cell 
growth and development, especially in nerve cells, as well as the cellular 
DNA synthesis [25, 29]. Overexpression of IGF-1R in cancer cells 
results in increased invasion and vice versa [31]. IGF-1 and its receptor 
(IGF-1R) are essential for embryo growth and survival. Endometrial 
decidual cells express IGF-1 gene in the implantation site [19], but IGF-
1 gene null mice have been shown to be infertile [2]. Maternal IGF-I 
stimulates fetal growth by activating the placental transport of nutrients 
to fetus [17]. In a case of fetus’s growth retardation, IGF-1 compen-
satory increasing had been established [23, 15]. Peripheral trophoblast 
cells of preeclamptic women demonstrated increased immunoreactivity 
as well [24]. We discovered IGF-1 and IGF-1R in gravid endometrium. 
The fallopian tube epithelium, trophoblast and connective tissue cells 
demonstrated a positive reaction for IGF-1 in our study, but IGF-1R in 
these structures was particularly absent. This finding may indicate the 
possible restriction of the cell’s growth and the restriction of trophoblast 
invasion in the tissues affected by ectopic pregnancy. Abundant 
distribution of IGF-1, bFGF and their receptors in the first trimester 
embryo developing organ systems suggests their participation in human 
embryogenesis. 
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CONCLUSIONS 
1.  IGF-1, IGF-1R, bFGF and FGFR1 are widely appearing growth 
factors in the actively developing and differentiating human 
embryonic tissue in the first trimester.  
2.  Both endometrial and fallopian tube tissues express more FGFR1 
than bFGF that testifies the stimulation of the compensatory 
adaptation of the organ during pregnancy. 
3.  IGF-1 and IGF-1R richly appears in gravid endometrium. 
4.  IGF-1 is widely distributed in both mother and embryo tissues but 
IGF-1R marked only some of them in a case of ectopic pregnancy. 
The deficit of IGF-1R in the fallopian tube might be a result of cell 
growth restriction and the impaired process of trophoblast invasion. 
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